#ICYMI: Plus Therapeutics added Dr. Andrew Brenner to our management team. Dr. Brenner will provide substantial input on the Company’s central nervous system cancer development programs while continuing to maintain his academic practice and laboratory.
Full Press Release: https://bit.ly/43VQ1Bq
#GBM #Metastatic #BreastCancer #LungCancer #BrainCancer #clinicaltrials #radiotherapy #healthcare #patients #caregivers #raredisease $PSTV
Recent Comments